Both drugs offer impressive results for weight loss and metabolic health benefits, but their high cost often makes access a challenge
However, it also comes with certain potential risks
Journal of Sleep Research: "Effects of Weight Loss on Obstructive Sleep Apnea Severity: 10-year Follow-Up Study." Journal of Sleep Research, 2014
[14] Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (as Mounjaro) and chronic weight management (as Zepbound)
Oral weight loss pills like Wegovy work through the same GLP-1 mechanism, so weight loss pills' side effects are similar to the injection, primarily mild nausea and constipation
Those with severe heart failure (ejection fraction below 30%) or active arrhythmias require special consideration because rapid weight loss or electrolyte shifts could theoretically destabilize cardiac function